respiratory syncytial virus Archives - Express Pharma

Respiratory syncytial virus prophylactic market to surpass $6 bn across 8MM in 2030

AstraZeneca India, Indian Academy of Paediatrics unite to raise awareness on respiratory syncytial virus in India

AstraZeneca to launch Palivizumab (Synagis) in India

US FDA expands approval to GSK’s Arexvy for adults aged 50-59, at increased risk

Moderna’s mRESVIA FDA approval paves way for mRNA vaccines across multiple indications: GlobalData

AstraZeneca and Sanofi Beyfortus to dominate RSV market in China: GlobalData

Biden administration to urge Americans get COVID-19 boosters

Pfizer and GSK to battle for share of new RSV vaccine market: GlobalData

New RSV therapies may accelerate the emergence of drug-resistant strains: GlobalData

Sanofi and AstraZeneca win EU approval for prevention of infant RSV